Buch, Englisch, Band 11, 392 Seiten, Format (B × H): 186 mm x 262 mm, Gewicht: 1034 g
Reihe: Contemporary Endocrinology
Buch, Englisch, Band 11, 392 Seiten, Format (B × H): 186 mm x 262 mm, Gewicht: 1034 g
Reihe: Contemporary Endocrinology
ISBN: 978-0-89603-591-1
Verlag: Humana Press
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
I Hormonal Control of Mammary Development and Growth.- 1 Hormonal Control of Normal Breast Morphology and Function.- 2 Interactions Between Estradiol and Progesterone in Normal Breast: Implications for Mammary Carcinogenesis.- 3 Expression and Regulation of Insulin-like Growth Factors and Their Binding Proteins in the Normal Breast.- II Carcinogenesis.- 4 Estrogens and Breast Cancer: An Epidemiologic Perspective.- 5 Androgens, Estrogens, and Breast Cancer Risk.- 6 Local Estrogen Production: Is Aromatase An Oncogene?.- 7 Oncogenes and Mammary Carcinogenesis.- 8 Categorization of Breast Cyst Fluid and Breast Cancer Risk.- III Tumor Progression.- 9 The Role of Tumor Suppressor Genes in Breast Cancer Progression.- 10 Oncogene Activation and Breast Cancer Progression.- 11 Interactions Between Stroma and Epithelium in Breast Cancer: Implications for Tumor Genesis, Growth, and Progression.- 12 The Role of Angiogenesis in the Transition to Hormone Independence and Acquisition of the Metastatic Phenotype.- 13 Role of the IGF System in Breast Cancer Proliferation and Progression.- 14 Prognostic and Predictive Factors in Breast Cancer.- 15 Role of the Polyamine Pathway in the Natural History of Breast Cancer.- IV Estrogen, Progestins, and Prolactin in Breast Cancer Biology: Targets for Treatment.- 16 Aromatase Inhibitors in Breast Carcinoma.- 17 Role of Progestins and Progesterone Receptors in Breast Cancer Biology.- 18 Prolactin and its Receptors in Human Breast Cancer.- V Endocrine Therapy of Breast Cancer.- 19 Pharmacology and Use of Antiestrogens in Treatment and Chemoprevention of Breast Cancer.- 20 LHRH Superagonists and Antagonists in the Treatment of Breast Cancer.- VI Benign Breast Disease.- 21 Benign Breast Lesions: Pathologic Classification and Risk Potential.- 22 Hormonal Treatment of Fibrocystic Disease.- 23 Gynecomastia and Galactorrhea.